ZEEK血栓抽吸导管对急诊经皮冠状动脉介入治疗的冠状动脉血流保护和手术支出的影响被引量：3

Impacts of ZEEK thrombus aspiration catheter on coronary blood flow protection and operating expenditure in primary percutaneous coronary intervention

下载PDF

导出

摘要目的探索急诊经皮冠状动脉介入(primary percutaneous coronary intervention,PPCI)治疗时使用血栓抽吸导管对冠状动脉血流保护作用以及对手术医疗支出的影响。方法回顾性分析2013年广东医学院附属福田医院心脏中心行PPCI治疗,术前冠状动脉造影显示罪犯血管心肌梗死溶栓(thrombolysis in myocardial infarction,TIMI)血流2级或以下,或有血栓X线影像的患者71例患者的临床资料。根据是否使用了血栓抽吸导管分为血栓抽吸组(34例)和常规手术组(37例)。对比两组的手术至首次恢复TIMI血流3级的时间;远端栓塞的发生率;术终保持TIMI血流3级的比例;球囊、支架用量;手术总费用。结果血栓抽吸不延长首次恢复TIMI血流3级的时间[(23.4±4.2)min vs.(24.1±7.7)min,P>0.05];显著减少远端栓塞(26.4%vs.54.1%,P<0.001);术终保持TIMI血流3级的比例与对照组比较,差异无统计学意义(94.1%vs.86.4%,P>0.05);显著减少平均预扩张球囊的使用(1.2 vs.0.8,P<0.01);不增加手术总费用。结论 PPCI治疗中在适宜的患者使用血栓抽吸导管可减少远端栓塞的同时不延长首次恢复TIMI血流3级的时间,可减少预扩张球囊的使用,不增加手术医疗支出。 Objectives To investigate the impacts of thrombus aspiration catheter（TAC） on coronary blood flow protection and operating expenditure in primary percutaneous coronary intervention（PPCI）. Methods Retrospective review on 71 cases receiving PPCI in Futian Hospital Affiliated to Guangdong Medical College in 2013 were analyzed.Patients with coronary thrombolysis in myocardial infarction（TIMI） blood flow grade 2 or lower, or with visible angiographic features indicating coronary thrombosis were enrolled into TAC group（34 cases） and traditional PPCI group（37 cases） according to the use of TAC. Time from operation to recovery to TIMI grade 3 blood flow（O-to-3）,incidence of distal embolism（DE）, ratio of patients with final TIMI grade 3 blood flow（FTR）, balloon consumption,stent consumption and operating expenditure（OE） between TAC group and traditional PPCI group were compared.Results TAC did not lengthen O-to-3 [（23.4±4.2） min vs.（24.1±7.7） min, P〉0.05] or increase FTR（94.1% vs.86.4%, P〉0.05）, but significantly reduced DE（26.4% vs. 54.1%,P〉0.001） and average pre-dilatation balloon consumption（1.2 vs. 0.8, P〈0.01）. There was no difference in OE. Conclusions Selective use of TAC in PPCI can reduce distal embolism without lengthening time from O-to-3, while reducing use of pre-dilatation balloon and bringing no additional medical expenditure.

作者吴奋生吴剑胜魏文斌程开诚胡淑芬吴施惠

机构地区广东医学院附属福田医院心脏中心

出处《岭南心血管病杂志》 2015年第3期309-311,共3页 South China Journal of Cardiovascular Diseases

关键词心肌梗死血管成形术经腔经皮冠状动脉血栓 myocardial infarction percutaneous coronary intervention thrombosis

分类号 R541.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献9

1LEVINE G N,BATES E R,BLANKENSHIP J C,et al. 2011ACCF/AHA/SCAI Guideline for Percutaneous CoronaryIntervention. A report of the American College of CardiologyFoundation/American Heart Association Task Force on PracticeGuidelines and the Society for Cardiovascular Angiography andInterventions[J]. Circulation, 2011, 124(23) : e574-651.
2STONE G W,MAEHARA A,WITZENBICHLER B, et al.Intracoronary abciximab and aspiration thrombectomy inpatients with large anterior myocardial infarction : the INFUSE-AMI randomized trial[J]. JAMA,2012,307( 17): 1817-1826.
3马利祥,王庆胜,巢永波,孟晓京,王文广,崔蕊,杨新春.ZEEK血栓抽吸导管在急性ST段抬高心肌梗死应用的临床观察[J].中华老年心脑血管病杂志,2013,15(4):430-431. 被引量：6
4颜红兵,赵汉军.血栓抽吸导管在心肌梗死急性期和恢复期介入治疗中的价值[J].中国循环杂志,2010,25(6):405-407. 被引量：23
5无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量：1978
6中国经皮冠状动脉介入治疗指南2012（简本）[J].中华心血管病杂志,2012,40(4):271-277. 被引量：426
7FREDERICK G, KUSHNER, MARY HAND, SIDNEY C,etal. 2009 Focused Updates : ACC/AHA Guidelines for theManagement of Patients With ST —Elevation MyocardialInfarction[J]. Circulation, 2009, 120(22) : 2271-2306.
8SARDELLA G, MANCONE M, BUCCIARELU-DUCCI C,etal. Thrombus aspiration during primary percutaneous coronaryintervention improves myo -cardial reperfusion and reducesinfarct size: the EXPIRA (throm-bectomy with export catheterin infarct -related artery during primary percutaneous coronaryintervention) prospective,randomized trial [ J] . J Am CollCardiol, 2009, 53 (4); 309-315.
9BURZOTTA F, DE VITA M, GU Y L, et al. Clinical impactof thrombectomy in acute ST -elevation myocardial infarction :an individual patient-data pooled analysis of 11 trials [J]. EurHeart J, 2009, 30 (18): 2193-2203.

二级参考文献17

1周斌全,傅国胜.直接PCI时远端保护装置对冠脉血流和心肌灌注水平的影响[J].中华急诊医学杂志,2007,16(6):592-595. 被引量：2
2Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量：43
3Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
4Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
5Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
6Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
7Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
8Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
9Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
10Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.